Vorasidenib Patent Expiration

Vorasidenib was first introduced by Servier Pharmaceuticals Llc in its drug Voranigo on Aug 6, 2024.

Vorasidenib Patents

Given below is the list of patents protecting Vorasidenib, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Voranigo	US11345677	Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same	Jan 16, 2039	Servier
Voranigo	US11844758	Therapeutically active compounds and their methods of use	Dec 04, 2035	Servier
Voranigo	US10172864	Therapeutically active compounds and their methods of use	Jul 11, 2034	Servier
Voranigo	US9579324	Therapeutically active compounds and their methods of use	Jul 11, 2034	Servier

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List